- Home
- COE vs PALI Comparison
COE vs PALI Comparison
Compare COE & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COE | PALI |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.1M | 268.6M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | COE | PALI |
|---|---|---|
| Price | $33.46 | $1.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 20.6K | ★ 5.0M |
| Earning Date | 12-08-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $81,215,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 93.72 | N/A |
| 52 Week Low | $13.60 | $0.53 |
| 52 Week High | $56.13 | $2.59 |
Technical Indicators
Market Signals| Indicator | COE | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 32.36 | 42.79 |
| Support Level | $31.89 | $1.65 |
| Resistance Level | $41.40 | $2.27 |
| Average True Range (ATR) | 2.55 | 0.18 |
| MACD | -0.48 | -0.04 |
| Stochastic Oscillator | 14.16 | 3.23 |
Price Performance
Historical ComparisonAbout COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand. The Group operates in seven principal geographical area: China, Hong Kong, Philippines, Singapore, Malaysia, Thailand and Saudi Arabia.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.